Ex-Legacy Pharmaceuticals machinery and equipment up for sale, says Hilco Industrial
Industrial assets purchaser is offering high-capacity production line equipment formerly owned by bankrupt CMO
Industrial assets purchaser Hilco Industrial Acquisitions says it is trying to bring back to the pharmaceutical market all machinery and equipment it purchased from bankrupt CMO Legacy Pharmaceuticals in a liquidation sale in March.
Switzerland-based Legacy, which specialised in fill/finish of sterile and semi-solid drug products, filed for bankruptcy in December 2020, resulting in over 200 job losses. At the time the company said the move had been driven by non-payment of important customers.
However, in October 2020, Legacy had been forced to stop manufacturing sterile drugs by Swissmedic after its facility failed an inspection by the Swiss drug regulator.
Darko Pepovski, Vice President Sales & Marketing of Hilco in the Netherlands, said his challenge is to bring the high-capacity production lines back to the market.
“To do so, we have started a worldwide marketing and sales campaign, making potential buyers in the pharmaceutical and associated industries aware of the opportunity to acquire the excellently maintained, late-model equipment needed, to increase their production capacities, especially in these days of high demand for injectables due to COVID,” he said.
To view the online auction for the ex-Legacy equipment, click here.
Related News
-
News Pharma Supply Chain People Moves
The latest appointments and promotions across the pharmaceutical supply chain. -
News Biosimilars save patients $11B annually, but barriers to adoption remain in US market
Biosimilars introduce competition into the biologics market, driving down prices and increasing patient access. -
News WHO recommends use of two monoclonal antibody treatments against Ebola
The health body recommended use of treatments by Regeneron and Ridgeback Bio -
News Sharp seeks greater foothold in Chinese market through ClinsChain partnership
Sharp hopes teaming up with clinical service provider ClinsChain will open the door to the Chinese market -
News GSK spins off consumer arm Haleon in biggest European listing for a decade
Haleon becomes the world’s biggest consumer health business, but debuted with a lower-than-expected valuation -
News SIGA reports $28M worth of new orders for monkeypox antiviral
The company has seen a sharp uptick in orders for its oral treatment as monkeypox cases rise globally -
News New CPHI report looks at CDMO outsourcing and partner selection
In The Future of Outsourcing - Strategies for Partner Selection, experts from across the pharma industry look at current trends impacting the contract services landscape and gauge the merits and drawbacks of the most common outsourcing strategies ... -
News CureVac files patent infringement lawsuit against BioNTech over mRNA technology
Company is seeking ‘fair compensation’ for alleged infringement of intellectual property rights relating to the use of mRNA tech to create the Pfizer-BioNTech COVID-19 vaccine
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance